FORT DETRICK, Md. – A process developed by the Medical Research and Development Command’s Medical Technology Transfer Office to help inventors ensure their biomedical technologies are ready for ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...

Biopharmaceutical manufacturers can strategically choose between fed-batch and continuous manufacturing to balance scalability, flexibility, and market demand across the product lifecycle. Understand ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

The sudden emergence of ChatGPT in 2022 kicked off a race to create new products powered by generative artificial intelligence (AI). Now, companies in all industries are trying to build the ability to ...

Aberdeen Proving Ground, MD -- Army leaders have long sought to simplify the process by which a good idea is transformed into innovative technology in the hands of warfighters. The steps in the ...

Intel Corp. is to announce Tuesday plans to build chips for handhelds and mobile phones on a separate version of its future manufacturing technology that greatly minimizes transistor current leakage, ...

GMDC: Technology is designed to recover Mixed Rare Earth Concentrate (MREC) from the Ambadungar hard-rock ankeritic ore.